Walgreens Boots Alliance, Inc. Share Price

Equities

WBA

US9314271084

Drug Retailers

Market Closed - Nasdaq 21:00:00 28/06/2024 BST 5-day change 1st Jan Change
12.1 USD -0.78% Intraday chart for Walgreens Boots Alliance, Inc. -24.26% -53.68%
Sales 2024 * 145B 11,504B Sales 2025 * 149B 11,757B Capitalization 10.44B 826B
Net income 2024 * -7.92B -627B Net income 2025 * 1.42B 112B EV / Sales 2024 * 0.13 x
Net Debt 2024 * 8.21B 649B Net Debt 2025 * 6.94B 549B EV / Sales 2025 * 0.12 x
P/E ratio 2024 *
-1.5 x
P/E ratio 2025 *
7.99 x
Employees 268,500
Yield 2024 *
10.5%
Yield 2025 *
7.97%
Free-Float 60.75%
More Fundamentals * Assessed data
Dynamic Chart
Boots CEO James quits after Walgreens' plans for sale stalls, Sky News reporter says RE
Walgreens' Q3 Earnings Miss Reflects Weak Consumer Spending, Pharmacy Headwinds, Morgan Stanley Says MT
Walgreens' Earnings Guidance Cut Implies 'Notably Weaker' Fourth Quarter, Morgan Stanley Says MT
Walgreens Boots Alliance's Fiscal Q3 Results Reflect Pharmacy Headwinds, Challenging Retail Environment, Truist Securities Says MT
BofA Securities Slashes Price Target on Walgreens Boots Alliance to $11 From $22, Maintains Underperform Rating MT
Truist Cuts Price Target on Walgreens Boots Alliance to $13 From $20, Calls Fiscal Q3 'Difficult,' Keeps Hold Rating MT
Mizuho Adjusts Price Target on Walgreens Boots Alliance to $15 From $19, Maintains Neutral Rating MT
Morgan Stanley Lowers Price Target on Walgreens Boots Alliance to $9 From $13 Amid Guidance Cut, Keeps Underweight Rating MT
Barclays Adjusts Price Target on Walgreens Boots Alliance to $11 From $15, Maintains Underweight Rating MT
Deutsche Bank Adjusts Price Target on Walgreens Boots Alliance to $13 From $22, Maintains Hold Rating MT
Wall St. subdued ahead of debate, inflation data RE
Equities Rise as Markets Analyze Fed Official's Remarks, Macro Data MT
Equities Rise Amid Fed Official's Rate Remarks, Macro Data MT
US Equities Markets Close Higher Thursday as Investors Review Economic Data, Fed Official's Remarks MT
Sector Update: Health Care Stocks Slipping Late Afternoon MT
More news
1 day-0.78%
1 week-24.26%
Current month-25.43%
1 month-18.77%
3 months-44.24%
6 months-53.68%
Current year-53.68%
More quotes
1 week
11.68
Extreme 11.68
16.25
1 month
11.68
Extreme 11.68
16.34
Current year
11.68
Extreme 11.68
27.05
1 year
11.68
Extreme 11.68
31.32
3 years
11.68
Extreme 11.68
55.00
5 years
11.68
Extreme 11.68
64.50
10 years
11.68
Extreme 11.68
97.30
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 22/10/23
Director of Finance/CFO 45 31/01/16
Chairman 83 31/07/12
Members of the board TitleAgeSince
Director/Board Member 57 26/10/22
Director/Board Member 67 28/10/20
Director/Board Member 68 31/03/10
More insiders
Date Price Change Volume
28/06/24 12.1 -0.78% 54,346,456
27/06/24 12.19 -22.16% 132,813,028
26/06/24 15.66 -0.25% 12,933,386
25/06/24 15.7 -1.32% 10,336,612
24/06/24 15.91 -0.38% 13,632,525

Delayed Quote Nasdaq, June 28, 2024 at 09:00 pm

More quotes
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
12.1 USD
Average target price
17.08 USD
Spread / Average Target
+41.24%
Consensus